Hughes Hubbard Assists Cipla in Acquisition of Avenue Therapeutics
Hughes Hubbard is serving as legal counsel to drugmaker Cipla in its pending acquisition of U.S.-based specialty pharmaceutical firm Avenue Therapeutics.
News & Events | Deals & Matters
Firm Wins Dismissal of SIBOR Claims Against Macquarie
The firm achieved a victory for Macquarie when a Manhattan federal judge threw out claims against the Australian investment bank for alleged manipulation of Singapore's benchmark interest rates.
News & Events | Deals & Matters
Firm Wins US Anti-Dumping Case for Japanese Steelmakers
​Hughes Hubbard earned a significant victory for the Japanese specialty steel industry when the U.S. International Trade Commission ended anti-dumping duties on stainless steel bars from Japan.
News & Events | Deals & Matters
​Hughes Hubbard Assists Grab in Record $1B Investment From Toyota
Hughes Hubbard is advising Singapore-based Grab in the sale of a $1 billion stake to Toyota Motor Corp. -- the biggest ever investment by an automaker in a ride-hailing firm.
News & Events | Deals & Matters
​Firm Helps Win Supreme Court Hearing for Merck Over Fosamax Suits
In an appeal being closely watched by the pharmaceutical industry, the firm helped Merck convince the U.S. Supreme Court that it should hear the pharmaceutical giant's appeal of a Third Circuit ruling that revived hundreds of lawsuits over Merck's alleged failure to warn about a risk of thigh bone fractures from its osteoporosis drug Fosamax.
News & Events | Deals & Matters
Hughes Hubbard Ranked Among Law360's Best Firms for Minority Attorneys
Hughes Hubbard was recognized as one of the best firms for minority attorneys in Law360's 2018 Diversity Snapshot.
News & Events | Diversity

Creative &
Collaborative Lawyers

Committed to Excellence Explore Our Practices

Grow With Us

Benefit from the firm's collegial and supportive culture